3rd Quarter - Report

GOVERNMENT COUNSEL, LLC for APOTEX CORPORATION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 987-Strengthening Health Care and Lowering Prescription Drug Costs (Section 101);S.1895-Lower Health Care Costs Act (Section 205); Issues relating to the global pharmaceutical supply chain.

Foreign entity interest: Aposherm Inc. and Apotex Holdings Inc., parent companies of Apotex Corp. identified on the LD-1, have direct or indirect interests in companies that develop, manufacture, and/or sell generic drugs and therefore are interested in the issues identified in this report.

LobbyistCovered position, as disclosed
HENRY W MENN Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1895 (116th), H.R. 987 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.